BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M, Candido S. Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging (Albany NY) 2018;10:1000-14. [PMID: 29779016 DOI: 10.18632/aging.101444] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 27.3] [Reference Citation Analysis]
Number Citing Articles
1 Ma J, Zhu M, Ye X, Wu B, Wang T, Ma M, Li T, Zhang N. Prognostic microRNAs associated with phosphoserine aminotransferase 1 in gastric cancer as markers of bone metastasis. Front Genet 2022;13:959684. [DOI: 10.3389/fgene.2022.959684] [Reference Citation Analysis]
2 Liang Y, Sun H, Ma B, Meng Q, Falzone L. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/4556585] [Reference Citation Analysis]
3 Zhang Q, Wang Z, Zhang Z, Zhu L, Yang X. Analysis of microarray-identified genes and MicroRNAs associated with Trifluridine resistance in colorectal cancer. All Life 2022;15:636-48. [DOI: 10.1080/26895293.2022.2080280] [Reference Citation Analysis]
4 Bayat A, Raad M, Sharafshah A, Ahmadvand M, Aminian H. Identification of miR-195-5p as a novel prognostic biomarker for colorectal cancer. Mol Biol Rep 2022. [PMID: 35587844 DOI: 10.1007/s11033-022-07462-6] [Reference Citation Analysis]
5 Jorgensen BG, Ro S. MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets. Int J Mol Sci 2022;23:2166. [PMID: 35216281 DOI: 10.3390/ijms23042166] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jhan JH, Hsu WC, Lee YC, Li WM, Huang AM, Lin HH, Wang CS, Wu YR, Li CC, Wu WJ, Ke HL. MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1. Cancers (Basel) 2022;14:880. [PMID: 35205628 DOI: 10.3390/cancers14040880] [Reference Citation Analysis]
7 Yun Z, Yue M, Kang Z, Zhang P. Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2. Exp Cell Res 2022;410:112936. [PMID: 34801563 DOI: 10.1016/j.yexcr.2021.112936] [Reference Citation Analysis]
8 Radanova M, Mihaylova G, Tasinov O, Ivanova DP, Stoyanov GS, Nazifova-tasinova N, Manev R, Salim A, Nikolova M, Ivanova DG, Conev N, Mihaylova Z, Donev I. New Circulating Circular RNAs with Diagnostic and Prognostic Potential in Advanced Colorectal Cancer. IJMS 2021;22:13283. [DOI: 10.3390/ijms222413283] [Reference Citation Analysis]
9 Wu H, Li C, Cui M, Guo H, Chen S, Du J, Li H, Li Z. Polyphenols from Hippophae rhamnoides suppressed colon cancer growth by regulating miRNA-mediated cell cycle arrest and apoptosis in vitro and in vivo. Journal of Functional Foods 2021;87:104780. [DOI: 10.1016/j.jff.2021.104780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sahlolbei M, Fattahi F, Vafaei S, Rajabzadeh R, Shiralipour A, Madjd Z, Kiani J. Relationship Between Low Expressions of tRNA-Derived Fragments with Metastatic Behavior of Colorectal Cancer. J Gastrointest Cancer 2021. [PMID: 34837147 DOI: 10.1007/s12029-021-00773-0] [Reference Citation Analysis]
11 Aranza-Martínez A, Sánchez-Pérez J, Brito-Elias L, López-Camarillo C, Cantú de León D, Pérez-Plasencia C, López-Urrutia E. Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer. Front Oncol 2021;11:752270. [PMID: 34804940 DOI: 10.3389/fonc.2021.752270] [Reference Citation Analysis]
12 Filetti V, Loreto C, Falzone L, Lombardo C, Cannizzaro E, Castorina S, Ledda C, Rapisarda V. Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma. J Pers Med 2021;11:1205. [PMID: 34834557 DOI: 10.3390/jpm11111205] [Reference Citation Analysis]
13 Butz H, Mészáros K, Likó I, Patocs A. Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs. Int J Mol Sci 2021;22:11778. [PMID: 34769207 DOI: 10.3390/ijms222111778] [Reference Citation Analysis]
14 Chen W, Chen Y, Zhang K, Yang W, Li X, Zhao J, Liu K, Dong Z, Lu J. AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma. Int Immunopharmacol 2021;101:108225. [PMID: 34655849 DOI: 10.1016/j.intimp.2021.108225] [Reference Citation Analysis]
15 Scioli MG, Terriaca S, Fiorelli E, Storti G, Fabbri G, Cervelli V, Orlandi A. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives. Int J Mol Sci 2021;22:10572. [PMID: 34638913 DOI: 10.3390/ijms221910572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wu YF, Wang CY, Tang WC, Lee YC, Ta HDK, Lin LC, Pan SR, Ni YC, Anuraga G, Lee KH. Expression Profile and Prognostic Value of Wnt Signaling Pathway Molecules in Colorectal Cancer. Biomedicines 2021;9:1331. [PMID: 34680448 DOI: 10.3390/biomedicines9101331] [Reference Citation Analysis]
17 Fonseca A, Ramalhete SV, Mestre A, Pires das Neves R, Marreiros A, Castelo-Branco P, Roberto VP. Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression. Aging (Albany NY) 2021;13:21991-2029. [PMID: 34547721 DOI: 10.18632/aging.203556] [Reference Citation Analysis]
18 Ota Y, Takahashi K, Otake S, Tamaki Y, Okada M, Yan I, Aso K, Fujii S, Patel T, Haneda M. Extracellular RNA transfer from non-malignant human cholangiocytes can promote cholangiocarcinoma growth. FEBS Open Bio 2021. [PMID: 34510808 DOI: 10.1002/2211-5463.13294] [Reference Citation Analysis]
19 Xu XL, Liu H, Zhang Y, Zhang SX, Chen Z, Bao Y, Li TK. SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma. Oncol Lett 2021;22:713. [PMID: 34457068 DOI: 10.3892/ol.2021.12974] [Reference Citation Analysis]
20 Yuan J, Wei Z, Xu X, Ocansey DKW, Cai X, Mao F. The Effects of Mesenchymal Stem Cell on Colorectal Cancer. Stem Cells Int 2021;2021:9136583. [PMID: 34349805 DOI: 10.1155/2021/9136583] [Reference Citation Analysis]
21 Al-Akhrass H, Christou N. The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer. Cancers (Basel) 2021;13:2916. [PMID: 34208056 DOI: 10.3390/cancers13122916] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 El-Derany MO, Noureldein MH. Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo. Stem Cell Res Ther 2021;12:322. [PMID: 34090498 DOI: 10.1186/s13287-021-02384-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mahmoud MM, Sanad EF, Hamdy NM. MicroRNAs' role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration. Environ Sci Pollut Res Int 2021;28:36984-7000. [PMID: 34046834 DOI: 10.1007/s11356-021-14550-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Han Z, Zhang C, Wang Q, Li L, Wang M, Li X, Yang C. MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway. Clin Med Insights Oncol 2021;15:11795549211012666. [PMID: 34017210 DOI: 10.1177/11795549211012666] [Reference Citation Analysis]
25 Agnoletto C, Caruso C, Garofalo C. Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice. Cancers (Basel) 2021;13:2189. [PMID: 34063272 DOI: 10.3390/cancers13092189] [Reference Citation Analysis]
26 Rezaei R, Baghaei K, Hashemi SM, Zali MR, Ghanbarian H, Amani D. Tumor-Derived Exosomes Enriched by miRNA-124 Promote Anti-tumor Immune Response in CT-26 Tumor-Bearing Mice. Front Med (Lausanne) 2021;8:619939. [PMID: 33987190 DOI: 10.3389/fmed.2021.619939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Liang H, Xu M, Xiong Z, Hu K, Yang J, Cao M, Zhong Z, Yao Z, Deng M, Liu B. Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma. Aging (Albany NY) 2021;13:6115-33. [PMID: 33617479 DOI: 10.18632/aging.202606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 de Los Santos-Jiménez J, Campos-Sandoval JA, Márquez-Torres C, Urbano-Polo N, Brøndegaard D, Martín-Rufián M, Lobo C, Peñalver A, Gómez-García MC, Martín-Campos J, Cardona C, Castilla L, da Costa Souza F, Cheng T, Segura JA, Alonso FJ, Curi R, Colquhoun A, DeBerardinis RJ, Márquez J, Matés JM. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. J Biomed Sci 2021;28:14. [PMID: 33610185 DOI: 10.1186/s12929-021-00712-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Dos Santos IL, Penna KGBD, Dos Santos Carneiro MA, Libera LSD, Ramos JEP, Saddi VA. Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review. Mol Biol Rep 2021;48:1853-67. [PMID: 33598796 DOI: 10.1007/s11033-020-06075-1] [Reference Citation Analysis]
30 Li Y, Sun W, Pan H, Yuan J, Xu Q, Xu T, Li P, Cheng D, Liu Y, Ni C. LncRNA-PVT1 activates lung fibroblasts via miR-497-5p and is facilitated by FOXM1. Ecotoxicol Environ Saf 2021;213:112030. [PMID: 33601175 DOI: 10.1016/j.ecoenv.2021.112030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Zhang L, Liu T, Chen H, Zhao Q, Liu H. Predicting lncRNA-miRNA interactions based on interactome network and graphlet interaction. Genomics 2021;113:874-80. [PMID: 33588070 DOI: 10.1016/j.ygeno.2021.02.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
32 Zhang X, Ma L, Zhai L, Chen D, Li Y, Shang Z, Zhang Z, Gao Y, Yang W, Li Y, Pan Y. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Int J Med Sci 2021;18:984-99. [PMID: 33456356 DOI: 10.7150/ijms.49126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Alves Dos Santos K, Clemente Dos Santos IC, Santos Silva C, Gomes Ribeiro H, de Farias Domingos I, Nogueira Silbiger V. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer. Int J Mol Sci 2020;22:E346. [PMID: 33396209 DOI: 10.3390/ijms22010346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Maugeri A, Barchitta M, Magnano San Lio R, Li Destri G, Agodi A, Basile G. Epigenetic Aging and Colorectal Cancer: State of the Art and Perspectives for Future Research. Int J Mol Sci 2020;22:E200. [PMID: 33379143 DOI: 10.3390/ijms22010200] [Reference Citation Analysis]
35 Žlajpah M, Boštjančič E, Tepeš B, Zidar N. Expression of Extracellular Matrix-Related Genes and Their Regulatory microRNAs in Problematic Colorectal Polyps. Cancers (Basel) 2020;12:E3715. [PMID: 33322258 DOI: 10.3390/cancers12123715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Liu S, Yin H, Zheng S, Chu A, Li Y, Xing C, Yuan Y, Gong Y. Differentially Expressed mRNAs and Their Long Noncoding RNA Regulatory Network with Helicobacter pylori-Associated Diseases including Atrophic Gastritis and Gastric Cancer. Biomed Res Int 2020;2020:3012193. [PMID: 33282942 DOI: 10.1155/2020/3012193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Aloizou AM, Pateraki G, Siokas V, Mentis AA, Liampas I, Lazopoulos G, Kovatsi L, Mitsias PD, Bogdanos DP, Paterakis K, Dardiotis E. The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention? Toxicol Rep 2020;7:1514-30. [PMID: 33251119 DOI: 10.1016/j.toxrep.2020.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Huang W, Yan YG, Wang WJ, Ouyang ZH, Li XL, Zhang TL, Wang XB, Wang B, Lv GH, Li J, Zou MX. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma. Front Oncol 2020;10:556902. [PMID: 33194623 DOI: 10.3389/fonc.2020.556902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A, Lombardo C. Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep 2020;13:60. [PMID: 33149905 DOI: 10.3892/br.2020.1367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
40 Fawzy MS, Ibrahiem AT, AlSel BTA, Alghamdi SA, Toraih EA. Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study. Sci Rep 2020;10:16940. [PMID: 33037254 DOI: 10.1038/s41598-020-73951-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Xing XL, Yao ZY, Zhang T, Zhu N, Liu YW, Peng J. MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer. Biomed Res Int. 2020;2020:7905380. [PMID: 32964043 DOI: 10.1155/2020/7905380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Falzone L, Grimaldi M, Celentano E, Augustin LSA, Libra M. Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity. Cancers (Basel) 2020;12:E2555. [PMID: 32911851 DOI: 10.3390/cancers12092555] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
43 Nikolouzakis TK, Falzone L, Lasithiotakis K, Krüger-Krasagakis S, Kalogeraki A, Sifaki M, Spandidos DA, Chrysos E, Tsatsakis A, Tsiaoussis J. Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. J Clin Med 2020;9:E2868. [PMID: 32899768 DOI: 10.3390/jcm9092868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
44 Sharma PC, Gupta A. MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers. Transl Cancer Res 2020;9:5798-818. [PMID: 35117940 DOI: 10.21037/tcr-20-1294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Saberinia A, Alinezhad A, Jafari F, Soltany S, Akhavan Sigari R. Oncogenic miRNAs and target therapies in colorectal cancer. Clinica Chimica Acta 2020;508:77-91. [DOI: 10.1016/j.cca.2020.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
46 Vacante M, Ciuni R, Basile F, Biondi A. The Liquid Biopsy in the Management of Colorectal Cancer: An Overview. Biomedicines. 2020;8. [PMID: 32858879 DOI: 10.3390/biomedicines8090308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
47 Ahadi A. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent. Noncoding RNA Res 2020;5:125-34. [PMID: 32954092 DOI: 10.1016/j.ncrna.2020.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
48 Zhang Y, Qin X, Jiang J, Zhao W. MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway. Oncol Lett 2020;20:1327-35. [PMID: 32724375 DOI: 10.3892/ol.2020.11687] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Pereira AL, Magalhães L, Pantoja RP, Araújo G, Ribeiro-Dos-Santos Â, Vidal AF. The Biological Role of Sponge Circular RNAs in Gastric Cancer: Main Players or Coadjuvants? Cancers (Basel) 2020;12:E1982. [PMID: 32708088 DOI: 10.3390/cancers12071982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Jiang L, Zhong M, Chen T, Zhu X, Yang H, Lv K. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme. J Cell Mol Med 2020;24:10075-87. [PMID: 32696617 DOI: 10.1111/jcmm.15615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 Xu L, Zhang L, Wang T, Wu Y, Pu X, Li M, Guo Y. ExoceRNA atlas: A database of cancer ceRNAs in human blood exosomes. Life Sci 2020;257:118092. [PMID: 32681912 DOI: 10.1016/j.lfs.2020.118092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Zhou Z, Zhou X, Jiang Y, Qiu M, Liang X, Lin Q, Guo Q, Nong C, Huo R, Chen Q, Liu H, Liu Y, Zhu S, Wang M, Yu H. Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation. Sci Rep 2020;10:11573. [PMID: 32665670 DOI: 10.1038/s41598-020-68450-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
53 Hou X, Hou N, Fu J, He X, Xiong H, Xie W, Jia G, Zuo X, Qin X, Pang M. Identification of Key mRNAs and Pathways in Colorectal Cancer. Nutr Cancer 2021;73:1040-6. [PMID: 32586129 DOI: 10.1080/01635581.2020.1783328] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Eizuka M, Osakabe M, Sato A, Fujita Y, Tanaka Y, Otsuka K, Sasaki A, Matsumoto T, Suzuki H, Sugai T. Dysregulation of microRNA expression during the progression of colorectal tumors. Pathol Int 2020;70:633-43. [PMID: 32592277 DOI: 10.1111/pin.12975] [Reference Citation Analysis]
55 Milanesi E, Dobre M, Bucuroiu AI, Herlea V, Manuc TE, Salvi A, De Petro G, Manuc M, Becheanu G. miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study. J Immunol Res 2020;2020:4927120. [PMID: 32676506 DOI: 10.1155/2020/4927120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Costa C, Teodoro M, Rugolo CA, Alibrando C, Giambò F, Briguglio G, Fenga C. MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure. Toxicol Rep 2020;7:759-67. [PMID: 32612936 DOI: 10.1016/j.toxrep.2020.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
57 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
58 Shang A, Wang X, Gu C, Liu W, Sun J, Zeng B, Chen C, Ji P, Wu J, Quan W, Yao Y, Wang W, Sun Z, Li D. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1. Aging (Albany NY) 2020;12:8352-71. [PMID: 32364530 DOI: 10.18632/aging.103145] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
59 Filetti V, Falzone L, Rapisarda V, Caltabiano R, Eleonora Graziano AC, Ledda C, Loreto C. Modulation of microRNA expression levels after naturally occurring asbestiform fibers exposure as a diagnostic biomarker of mesothelial neoplastic transformation. Ecotoxicol Environ Saf 2020;198:110640. [PMID: 32330788 DOI: 10.1016/j.ecoenv.2020.110640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
60 Cojocneanu R, Braicu C, Raduly L, Jurj A, Zanoaga O, Magdo L, Irimie A, Muresan MS, Ionescu C, Grigorescu M, Berindan-Neagoe I. Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients. Cancers (Basel) 2020;12:E843. [PMID: 32244548 DOI: 10.3390/cancers12040843] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
61 Abedi P, Bayat A, Ghasemzadeh S, Raad M, Pashaiefar H, Ahmadvand M. Upregulated miR-410 is linked to poor prognosis in colorectal cancer. Br J Biomed Sci 2020;77:118-22. [PMID: 32065051 DOI: 10.1080/09674845.2020.1731050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Zhang Y, Liu X, Zhang J, Xu Y, Shao J, Hu Y, Shu P, Cheng H. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway. Aging (Albany NY) 2020;12:5640-50. [PMID: 32209726 DOI: 10.18632/aging.102929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
63 Vivarelli S, Falzone L, Basile MS, Candido S, Libra M. Nitric Oxide in Hematological Cancers: Partner or Rival? Antioxid Redox Signal 2021;34:383-401. [PMID: 32027171 DOI: 10.1089/ars.2019.7958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 La Rosa GRM, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett 2020;19:3045-58. [PMID: 32211076 DOI: 10.3892/ol.2020.11441] [Cited by in Crossref: 13] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
65 Siokas V, Aslanidou P, Aloizou A, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease? J Mol Neurosci 2020;70:851-60. [DOI: 10.1007/s12031-020-01507-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
66 Mao Z, Zhao H, Qin Y, Wei J, Sun J, Zhang W, Kang Y. Post-Transcriptional Dysregulation of microRNA and Alternative Polyadenylation in Colorectal Cancer. Front Genet 2020;11:64. [PMID: 32153636 DOI: 10.3389/fgene.2020.00064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
67 Basile MS, Mazzon E, Mangano K, Pennisi M, Petralia MC, Lombardo SD, Nicoletti F, Fagone P, Cavalli E. Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis. Brain Sci 2020;10:E52. [PMID: 31963428 DOI: 10.3390/brainsci10010052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
68 Wei W, Mo X, Yan L, Huang M, Yang Y, Jin Q, Zhong H, Cao W, Wu K, Wu L, Li Z, Wang T, Qin Y, Chen J. Circular RNA Profiling Reveals That circRNA_104433 Regulates Cell Growth by Targeting miR-497-5p in Gastric Cancer. Cancer Manag Res 2020;12:15-30. [PMID: 32021419 DOI: 10.2147/CMAR.S219307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
69 Li L, Feng T, Zhang W, Gao S, Wang R, Lv W, Zhu T, Yu H, Qian B. MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer. Int J Genomics 2020;2020:7415909. [PMID: 31976313 DOI: 10.1155/2020/7415909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
70 Wen J, Hall B, Shi X. A network view of microRNA and gene interactions in different pathological stages of colon cancer. BMC Med Genomics 2019;12:158. [PMID: 31888617 DOI: 10.1186/s12920-019-0597-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Hasegawa N, Takeda Nakamura I, Ueno T, Kojima S, Kawazu M, Akaike K, Okubo T, Takagi T, Suehara Y, Hayashi T, Saito T, Kaneko K, Mano H, Kohsaka S. Detection of circulating sarcoma tumor cells using a microfluidic chip-type cell sorter. Sci Rep 2019;9:20047. [PMID: 31882696 DOI: 10.1038/s41598-019-56377-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
72 Desmond BJ, Dennett ER, Danielson KM. Circulating Extracellular Vesicle MicroRNA as Diagnostic Biomarkers in Early Colorectal Cancer-A Review. Cancers12:52. [PMID: 31878015 DOI: 10.3390/cancers12010052] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
73 Sato A, Fujita Y, Otsuka K, Sasaki A, Suzuki H, Matsumoto T, Sugai T. Differential expression of microRNAs in colorectal cancer: Different patterns between isolated cancer gland and stromal cells. Pathol Int 2020;70:21-30. [PMID: 31750597 DOI: 10.1111/pin.12872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
74 Moradi-Marjaneh R, Khazaei M, Ferns GA, Aghaee-Bakhtiari SH. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer. Curr Pharm Des 2018;24:4611-8. [PMID: 30636580 DOI: 10.2174/1381612825666190110150705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
75 Nováková T, Macháčková T, Novák J, Hude P, Godava J, Žampachová V, Oppelt J, Zlámal F, Němec P, Bedáňová H, Slabý O, Bienertová-Vašků J, Špinarová L, Krejčí J. Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing. Cells 2019;8:E1400. [PMID: 31698874 DOI: 10.3390/cells8111400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, Tzanakakis G, Libra M, Tsatsakis A. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 2019;8:E1251. [PMID: 31615102 DOI: 10.3390/cells8101251] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
77 Qi Z, Yuan L, Sun N. Propofol exhibits a tumor-suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA-10b/HOXD10 signaling pathway. Oncol Lett 2019;18:6228-36. [PMID: 31788099 DOI: 10.3892/ol.2019.10968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
78 Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current Perspectives in Cancer Immunotherapy. Cancers (Basel) 2019;11:E1472. [PMID: 31575023 DOI: 10.3390/cancers11101472] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 21.3] [Reference Citation Analysis]
79 Drev D, Harpain F, Beer A, Stift A, Gruber ES, Klimpfinger M, Thalhammer S, Reti A, Kenner L, Bergmann M, Marian B. Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells. Cancers (Basel) 2019;11:E1421. [PMID: 31554208 DOI: 10.3390/cancers11101421] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
80 Soleimani A, Rahmani F, Saeedi N, Ghaffarian R, Khazaei M, Ferns GA, Avan A, Hassanian SM. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem 2019;120:19245-53. [PMID: 31512778 DOI: 10.1002/jcb.29268] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
81 Xu C, Meng LB, Duan YC, Cheng YJ, Zhang CM, Zhou X, Huang CB. Screening and identification of biomarkers for systemic sclerosis via microarray technology. Int J Mol Med 2019;44:1753-70. [PMID: 31545397 DOI: 10.3892/ijmm.2019.4332] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
82 Meng LB, Shan MJ, Qiu Y, Qi R, Yu ZM, Guo P, Di CY, Gong T. TPM2 as a potential predictive biomarker for atherosclerosis. Aging (Albany NY) 2019;11:6960-82. [PMID: 31487691 DOI: 10.18632/aging.102231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
83 Gmerek L, Martyniak K, Horbacka K, Krokowicz P, Scierski W, Golusinski P, Golusinski W, Schneider A, Masternak MM. MicroRNA regulation in colorectal cancer tissue and serum. PLoS One 2019;14:e0222013. [PMID: 31469874 DOI: 10.1371/journal.pone.0222013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
84 Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 20.7] [Reference Citation Analysis]
85 Zheng S, Zhong Y, Tan D, Xu Y, Chen H, Wang D. miR-183-5p enhances the radioresistance of colorectal cancer by directly targeting ATG5. J Biosci 2019;44. [DOI: 10.1007/s12038-019-9918-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
86 Cheng Y, Cheng T, Zhao Y, Qu Y. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma. Cell Signal 2019;63:109386. [PMID: 31394192 DOI: 10.1016/j.cellsig.2019.109386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
87 Wen M, Qu X, Zhu Y, Tian L, Shen Z, Yang X, Shi X. Exploration of Novel Biomarkers in Vasculitis by Integrated Bioinfomatic Approaches. J Comput Biol 2019;26:1448-57. [PMID: 31356108 DOI: 10.1089/cmb.2019.0176] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Larcher LM, Wang T, Veedu RN. Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells. Molecules 2019;24:E2489. [PMID: 31284665 DOI: 10.3390/molecules24132489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
89 Bai J, Xu J, Zhao J, Zhang R. lncRNA SNHG1 cooperated with miR-497/miR-195-5p to modify epithelial-mesenchymal transition underlying colorectal cancer exacerbation. J Cell Physiol 2020;235:1453-68. [PMID: 31276207 DOI: 10.1002/jcp.29065] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
90 Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M, Falzone L. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep 2019;42:911-22. [PMID: 31322245 DOI: 10.3892/or.2019.7215] [Cited by in Crossref: 34] [Cited by in F6Publishing: 54] [Article Influence: 11.3] [Reference Citation Analysis]
91 Cirillo F, Catellani C, Sartori C, Lazzeroni P, Amarri S, Street ME. Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play A Role? Int J Mol Sci 2019;20:E2922. [PMID: 31207998 DOI: 10.3390/ijms20122922] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
92 Teodoro M, Briguglio G, Fenga C, Costa C. Genetic polymorphisms as determinants of pesticide toxicity: Recent advances. Toxicol Rep 2019;6:564-70. [PMID: 31293901 DOI: 10.1016/j.toxrep.2019.06.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
93 Vivarelli S, Falzone L, Basile M, Nicolosi D, Genovese C, Libra M, Salmeri M. Benefits of using probiotics as adjuvants in anticancer therapy (Review). Wrld Acd Sci 2019. [DOI: 10.3892/wasj.2019.13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
94 Falzone L, Lupo G, La Rosa GRM, Crimi S, Anfuso CD, Salemi R, Rapisarda E, Libra M, Candido S. Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer. Cancers (Basel) 2019;11:E610. [PMID: 31052345 DOI: 10.3390/cancers11050610] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
95 Yuan C, Steer CJ, Subramanian S. Host⁻MicroRNA⁻Microbiota Interactions in Colorectal Cancer. Genes (Basel) 2019;10:E270. [PMID: 30987065 DOI: 10.3390/genes10040270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
96 Kroupa R, Ondrackova M, Kovalcikova P, Dastych M, Pavlik T, Kunovsky L, Dolina J. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic. World J Gastroenterol 2019; 25(9): 1132-1141 [PMID: 30863000 DOI: 10.3748/wjg.v25.i9.1132] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
97 Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S. Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep 2019;19:2599-610. [PMID: 30816460 DOI: 10.3892/mmr.2019.9949] [Cited by in Crossref: 34] [Cited by in F6Publishing: 54] [Article Influence: 11.3] [Reference Citation Analysis]
98 Yuan J, Dong R, Liu F, Zhan L, Liu Y, Wei J, Wang N. The miR-183/182/96 cluster functions as a potential carcinogenic factor and prognostic factor in kidney renal clear cell carcinoma. Exp Ther Med 2019;17:2457-64. [PMID: 30906433 DOI: 10.3892/etm.2019.7221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
99 Vacante M, Borzì AM, Basile F, Biondi A. Biomarkers in colorectal cancer: Current clinical utility and future perspectives. World J Clin Cases 2018; 6(15): 869-881 [PMID: 30568941 DOI: 10.12998/wjcc.v6.i15.869] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 63] [Article Influence: 17.8] [Reference Citation Analysis]
100 Balacescu O, Sur D, Cainap C, Visan S, Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C, Irimie A. The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases. Int J Mol Sci 2018;19:E3711. [PMID: 30469518 DOI: 10.3390/ijms19123711] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
101 Gock M, Mullins CS, Bergner C, Prall F, Ramer R, Göder A, Krämer OH, Lange F, Krause BJ, Klar E, Linnebacher M. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines. World J Gastroenterol 2018; 24(43): 4880-4892 [PMID: 30487698 DOI: 10.3748/wjg.v24.i43.4880] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
102 Liu Y, Zhu J, Ma X, Han S, Xiao D, Jia Y, Wang Y. ceRNA network construction and comparison of gastric cancer with or without Helicobacter pylori infection. J Cell Physiol 2019;234:7128-40. [DOI: 10.1002/jcp.27467] [Cited by in Crossref: 14] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
103 Malcomson FC, Willis ND, McCallum I, Xie L, Kelly S, Bradburn DM, Belshaw NJ, Johnson IT, Mathers JC. Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and WNT-pathway-related markers of bowel cancer risk. Br J Nutr 2019;122:509-17. [PMID: 30255827 DOI: 10.1017/S0007114518002520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
104 Lin SS, Peng CY, Liao YW, Chou MY, Hsieh PL, Yu CC. miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas. Cancers (Basel) 2018;10:E272. [PMID: 30115848 DOI: 10.3390/cancers10080272] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]